Thalidomide reveals path for targeting "undruggable" transcription factors for cancer treatment
Laboratory study suggests that thalidomide-like drugs could be designed to target a broad array of transcription factors, and open a new landscape of cancer drug development.

Credit: Susanna M. Hamilton, Broad Communications